comparemela.com

Latest Breaking News On - Van poznak - Page 1 : comparemela.com

Biden s role in higher gas prices

Biden s role in higher gas prices
palmbeachpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from palmbeachpost.com Daily Mail and Mail on Sunday newspapers.

Landmark study finds how often cancer patients develop osteonecrosis of the jaw

Landmark study finds how often cancer patients develop osteonecrosis of the jaw A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has found that 2.8 percent of patients on average develop osteonecrosis of the jaw, or ONJ, within three years of starting a common treatment for cancer that has spread to the bone. Appearing in JAMA Oncology, the findings are important because the treatment, zoledronic acid, is prescribed to tens of thousands of patients whose cancer has spread to the bone. Almost all forms of cancer can spread, or metastasize, to bone but the most common are lung, breast, and prostate cancers and multiple myeloma. Zoledronic acid can protect bone, but is associated with a risk of ONJ, which causes exposed bone in the jaw that does not heal. This causes inflammation and pain in the mouth, and people with ONJ may have troub

Researchers determine how often cancer patients develop osteonecrosis of the jaw

 E-Mail IMAGE: Dr. Catherine Van Poznak is the co-chair of a new SWOG Cancer Research Network trial that details, for the first time, the incidence of a common bone disease in cancer. view more  Credit: University of Michigan Rogel Cancer Center PORTLAND, OR - A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has found that 2.8 percent of patients on average develop osteonecrosis of the jaw, or ONJ, within three years of starting a common treatment for cancer that has spread to the bone.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.